Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,669,708 papers from all fields of science
Search
Sign In
Create Free Account
HO 221
Known as:
HO-221
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Mechanism of tumor cell killing by HO-221, a novel antitumor compound
T. Nakajima
,
T. Okamoto
,
+5 authors
T. Taguchi
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 20352756
SummaryThe mechanism of tumor cell killing by HO-221, a novel benzoylphenylurea derivative that shows broad-spectrum antitumor…
Expand
2004
2004
Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221
T. Nakajima
,
H. Masuda
,
+6 authors
T. Taguchi
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 24092317
SummaryA novel antitumor compound,N-[4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl]-N′-(2-nitrobenzoyl) urea (HO-221) was evaluated…
Expand
2003
2003
Effect of novel benzoylphenylurea derivatives on DNA polymerase α activity using the synthesome-based in vitro model system
Waleed Abdel‐Aziz
,
R. Hickey
,
M. Edelman
,
L. Malkas
Investigational new drugs
2003
Corpus ID: 21251492
Six benzoylphenylurea (BPU) derivatives have been synthesized in Japan and extensively evaluated by the U.S. National Cancer…
Expand
Highly Cited
1993
Highly Cited
1993
Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region.
N. Kondo
,
T. Iwao
,
+6 authors
K. Yokoyama
Chemical and pharmaceutical bulletin
1993
Corpus ID: 33852761
N-[[[4-(5-Bromo-2-pyrimidinyloxy)-3-chlorophenyl]amino]carbonyl]-2 -nitrobenzamide (HO-221) is being developed as an anticancer…
Expand
1993
1993
Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals.
N. Kondo
,
T. Iwao
,
+5 authors
S. Ogyu
Biological and Pharmaceutical Bulletin
1993
Corpus ID: 22202018
N-[[[4-(5-Bromo-2-pyrimidinyloxy)-3-chlorophenyl]amino]carbonyl] - 2-nitrobenzamide (HO-221) is presently under development as an…
Expand
1991
1991
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
F. Fujita
,
M. Fujita
,
H. Inaba
,
T. Sugimoto
,
Y. Okuyama
,
T. Taguchi
Gan to kagaku ryoho. Cancer & chemotherapy
1991
Corpus ID: 7945610
Antitumor effect of HO-221, a derivative of benzoylphenylurea, has been previously studied against seven human cancer xenografts…
Expand
1991
1991
[Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
T. Nakajima
,
H. Masuda
,
+5 authors
T. Taguchi
Gan to kagaku ryoho. Cancer & chemotherapy
1991
Corpus ID: 45789197
Combined effect of N-[4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl]-N'-(2-nitrobenzoyl ) urea, HO-221, with various antitumor…
Expand
1991
1991
[Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
T. Nakajima
,
H. Masuda
,
+6 authors
T. Taguchi
Gan to kagaku ryoho. Cancer & chemotherapy
1991
Corpus ID: 23590332
HO-221, N-[4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl]-N'-(2- nitrobenzoyl) urea is a new benzoylphenylurea derivative. The…
Expand
1990
1990
[Antitumor effect of a benzoylphenylurea derivative HO-221].
T. Nakajima
,
H. Masuda
,
+5 authors
T. Taguchi
Gan to kagaku ryoho. Cancer & chemotherapy
1990
Corpus ID: 3192021
HO-221, N-[4-(5-Bromo-2-pyrimidinyloxy)-3-chlorophenyl]-N'-(2-nitrobenzoyl ) urea is a novel benzoylphenylurea derivative. We had…
Expand
1990
1990
[Mechanism of antitumor effect of a benzoylphenylurea derivative, HO-221].
T. Nakajima
,
T. Okamoto
,
+5 authors
T. Taguchi
Gan to kagaku ryoho. Cancer & chemotherapy
1990
Corpus ID: 41902290
HO-221, N-[4-(5-Bromo-2-pyrimidinyloxy)-3-chlorophenyl]-N'-(2-nitrobenzoyl ) urea is a novel benzoylphenylurea derivative. We…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE